Optometrists in Bel Air, MD Accepting Medicare

26 Optometrists found. Showing 1 - 20

Nguyen Ly, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 659 Bel Air Road, Bel Air, MD 21014 Phone: 410-838-1188    Fax: 410-838-4629

Parris Castoro Vision Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 620 Boulton St, Bel Air, MD 21014 Phone: 410-893-0480    Fax: 410-893-9796

Dr. Grace M. Kim, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 513 Baltimore Pike, Bel Air, MD 21014 Phone: 410-836-0098    Fax: 410-836-0104

Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 623 Bel Air Rd, Bel Air, MD 21014 Phone: 410-879-0044    Fax: 410-893-6871

Halpern Eye Care Of Maryland, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5 Bel Air South Pkwy, Suite 117, Bel Air, MD 21015 Phone: 410-569-0500    Fax: 410-569-0502

Professional Vision Of Bel Air Inc Optometrist Medicare: Medicare Enrolled Practice Location: 530 Baltimore Pike, Bel Air, MD 21014 Phone: 410-879-1105

Dominic Letray Brown, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5 Bel Air South Pkwy Ste 1317, Bel Air, MD 21015 Phone: 410-569-8113    Fax: 410-569-8585

Stephen Cyford, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 620 Boulton St, Bel Air, MD 21014 Phone: 410-836-7010

Parris Castoro Eye And Laser Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 620 Boulton St, Bel Air, MD 21014 Phone: 410-893-0480    Fax: 410-893-9796

Richard Corea, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 620 Boulton St, Bel Air, MD 21014 Phone: 410-836-7010

Dr. Jeffrey R Kessler, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 530 Baltimore Pike, Bel Air, MD 21014 Phone: 410-879-1105    Fax: 410-838-6681

Dr. Michelle Jager Centi, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 223 Brierhill Dr Ste C, Bel Air, MD 21015 Phone: 410-420-3933    Fax: 410-420-6399

Dr. Daniel C. Hunsicker, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 698 Baltimore Pike, Bel Air, MD 21014 Phone: 410-879-0044    Fax: 410-893-6871

Associated Eye Care Optometry Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2227 Old Emmorton Rd, Ste 114, Bel Air, MD 21015 Phone: 410-569-7173    Fax: 410-569-7123

Myeyedr Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5 Bel Air South Pkwy, #117, Bel Air, MD 21015 Phone: 410-569-0500

Dr. Jillian Sue Chapman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 623 Bel Air Rd, Bel Air, MD 21014 Phone: 410-879-0044

Dr. Melissa Beth Dempsey-connolly, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5 Bel Air South Pkwy, Bel Air, MD 21015 Phone: 410-569-8113    Fax: 410-569-8585

Joon Boaz Hur, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 104 Plumtree Rd Ste 107, Bel Air, MD 21015 Phone: 410-569-7173    Fax: 410-569-7123

America's Best Contacts & Eyeglasses Optometrist Medicare: Not Enrolled in Medicare Practice Location: 513 Baltimore Pike, Bel Air, MD 21014 Phone: 410-836-0098

Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5 Bel Air South Pkwy, Suite 1317, Bel Air, MD 21015 Phone: 410-569-8113

News Archive

Countdown begins for GP11 – The Conference for General Practice

With only six weeks to go until the Royal Australian College of General Practitioner's (RACGP) annual conference - GP11, final preparations are well underway for what will be an outstanding program of presentations, workshops and social networking opportunities for GPs and allied healthcare professionals.

FDA approves Mallinckrodt's EXALGO (32 mg) sNDA to manage opioid-related pain

Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.

State roundup: Calif., Oregon grappling with insurance rate increases; Kansas (almost) ready to launch health info network

California Insurance Commissioner Dave Jones denied Blue Shield of California's plan to close several of its health policies to new customers, saying it violated state rules designed to protect consumers from large rate increases. ... Blue Shield, a nonprofit insurer with 3.3 million members statewide, had proposed closing off new enrollment on 22 health plans with about 152,000 customers.

FDA announces new initiative to modernize regulation of clinical trials

FDA announces new policy and regulatory developments to strengthen the Agency's oversight and protection of patients in clinical trials and the integrity of resulting data in an effort to modernize the agency's approach to bioresearch monitoring as part of the Critical Path Initiative.

Research presents theoretical model that predicts HFE values of organic compounds

Drug delivery inside the body is a complicated process. Compounds travel through a maze of aqueous solutions, lipid membranes, and barriers between the blood and tissues like the brain. Research reported in the American Institute of Physics publication the Journal of Chemical Physics presents a theoretical model that accurately predicts the hydration free energy of a wide variety of organic compounds.

Read more Medical News

› Verified 1 days ago

• 1(current)
• 2